World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   6189 records for 1064 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3 4 5 6 7 8 9 10 Last
Recruitment statusMain ID Public TitleDate of Registration
RecruitingNCT02260986
Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Patients With Moderate-to-Severe Atopic Dermatitis
06/10/2014
RecruitingNCT02226120
Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction
25/08/2014
AuthorisedEUCTR2014-000747-32-DE
A phase 3 clinical trial to compare the efficacy and safety of Mylan's Insulin Glargine with commercial Insulin Glargine (Lantus®) in patients with type 1 diabetes 11/08/2014
AuthorisedEUCTR2013-000508-40-BE
This is a multinational research study comparing liquid or tablets of medicine Fidaxomicin versus liquid or capsules of medicine Vancomycin in children having Diarrhea caused with bacteria named Clostridium difficile 07/08/2014
AuthorisedEUCTR2012-002862-11-EE
Not available 06/08/2014
AuthorisedEUCTR2014-001976-75-SE
Study to Assess the Effect of Evolocumab on Ability to Learn Compared with Placebo in patients with Cardiovascular Disease who are already taking Statin Therapy.
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2014-001976-75-FIStudy to Assess the Effect of Evolocumab on Ability to Learn Compared with Placebo in patients with Cardiovascular Disease who are already taking Statin Therapy.11/08/2014
AuthorisedEUCTR2014-001976-75-SKStudy to Assess the Effect of Evolocumab on Ability to Learn Compared with Placebo in patients with Cardiovascular Disease who are already taking Statin Therapy.26/08/2014
AuthorisedEUCTR2014-001976-75-EEStudy to Assess the Effect of Evolocumab on Ability to Learn Compared with Placebo in patients with Cardiovascular Disease who are already taking Statin Therapy.12/08/2014
AuthorisedEUCTR2014-001976-75-LVStudy to Assess the Effect of Evolocumab on Ability to Learn Compared with Placebo in patients with Cardiovascular Disease who are already taking Statin Therapy.15/09/2014
AuthorisedEUCTR2014-001976-75-LTStudy to Assess the Effect of Evolocumab on Ability to Learn Compared with Placebo in patients with Cardiovascular Disease who are already taking Statin Therapy.17/09/2014
AuthorisedEUCTR2014-001976-75-CZStudy to Assess the Effect of Evolocumab on Ability to Learn Compared with Placebo in patients with Cardiovascular Disease who are already taking Statin Therapy.18/09/2014
AuthorisedEUCTR2014-001976-75-PTStudy to Assess the Effect of Evolocumab on Ability to Learn Compared with Placebo in patients with Cardiovascular Disease who are already taking Statin Therapy.22/09/2014
AuthorisedEUCTR2014-001976-75-GRStudy to Assess the Effect of Evolocumab on Ability to Learn Compared with Placebo in patients with Cardiovascular Disease who are already taking Statin Therapy.31/07/2014
30/07/2014
AuthorisedEUCTR2014-001473-14-SE
OS Study of pembrolizumab (MK-3475) vs. SOC in Treatment Naïve Subjects with PD-L1 Positive Advanced or Metastatic NSCLC (Keynote 042) 24/07/2014
AuthorisedEUCTR2013-004435-72-CZ
An open-label extension and safety monitoring study for patients with ulcerative colitis previously enrolled in etrolizumab phase III studies
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2013-004435-72-LVAn open-label extension and safety monitoring study for patients with ulcerative colitis previously enrolled in etrolizumab phase III studies22/07/2014
AuthorisedEUCTR2013-004435-72-ATAn open-label extension and safety monitoring study for patients with ulcerative colitis previously enrolled in etrolizumab phase III studies22/07/2014
AuthorisedEUCTR2013-004435-72-HRAn open-label extension and safety monitoring study for patients with ulcerative colitis previously enrolled in etrolizumab phase III studies05/09/2014
AuthorisedEUCTR2013-004435-72-LTAn open-label extension and safety monitoring study for patients with ulcerative colitis previously enrolled in etrolizumab phase III studies22/07/2014
AuthorisedEUCTR2013-004435-72-NOAn open-label extension and safety monitoring study for patients with ulcerative colitis previously enrolled in etrolizumab phase III studies06/08/2014
AuthorisedEUCTR2013-004435-72-EEAn open-label extension and safety monitoring study for patients with ulcerative colitis previously enrolled in etrolizumab phase III studies29/07/2014
AuthorisedEUCTR2013-004435-72-HUAn open-label extension and safety monitoring study for patients with ulcerative colitis previously enrolled in etrolizumab phase III studies30/10/2014
AuthorisedEUCTR2013-004435-72-GRAn open-label extension and safety monitoring study for patients with ulcerative colitis previously enrolled in etrolizumab phase III studies20/08/2014
21/07/2014
AuthorisedEUCTR2013-005412-10-AT
A multicenter, randomized clinical study to see how efficient, safe and well tolerated OCR-002 new drug candidate is in patients who suffer from cirrhosis and high ammonia level in blood with an onset of encephalopathy caused by abnormal liver activity 07/07/2014
AuthorisedEUCTR2014-000419-15-LV
Study to Compare the Efficacy and Safety of Single Dose Dalbavancin to a Two Dose Regimen of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections 04/07/2014
    
1 2 3 4 5 6 7 8 9 10 Last
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history